Patients with Rett syndrome exhibit neurodevelopmental defects associated with MeCP2 mutations, which encode methyl CpG binding protein 2 and bind to methylated DNA (Ballestar et al., 2000; Hansen et al., 2010). This evidence concerns the gene MECP2 and Rett syndrome.